-
What would you think about a drug that has been covered in the New York Times, 60 Minutes, CNN, and Forbes? Surely it’s a blockbuster and cures cancer, prevents heart attacks, or perhaps even prevents kidney failure? [read more...] -
PathPointers highlight important everyday teaching points when reviewing kidney histology. These brief and easy-to-read blog posts include real clinical images to demonstrate various biopsy findings. In this PathPointer [read more...] -
The United States Secretary of Health & Human Services, Alex Azar, recently highlighted in a speech at the National Kidney Foundation’s Kidney Patient Summit the fact that due to misaligned financial incentives, we are [read more...] -
An arteriovenous fistula (AVF) is a unique vascular structure leading to distinctive endothelial insults which may contribute to non-maturation or failure of the access. Up to 50% of AVFs undergo aberrant remodeling leading [read more...] -
The AJKD editors are excited to continue the Editorial Internship Program for a second year, and thank all the fellows who responded to the recent call for applications. Without further ado, we present the AJKD Editorial [read more...]
July 2019
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIRenal Amyloidosis – What We Need to Consider, Practical Tips
-
Atlas of Renal Pathology IIAcute and Chronic Antibody-Mediated Rejection Represent a Continuum of Endothelial Injury Involving Multiple Immune Mechanisms
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 5
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: Sampling Error in Misdiagnosis
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 4
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 3
-
Atlas of Renal Pathology IIPractical Tips for the Diagnosis of Acute Antibody-Mediated Rejection
-
Atlas of Renal Pathology IIRecurrent and De Novo FSGS Following Kidney Transplantation
